FDA Approves New Oral Medication for High Cholesterol

The U.S. Food and Drug Administration has given its approval to Lipfendra (enlicitide), an oral tablet designed for daily use to treat elevated cholesterol levels. This new therapy is intended to be used in conjunction with diet and exercise to lower LDL-C in adults, including those with heterozygous familial hypercholesterolemia. This approval offers a new and convenient treatment option for individuals managing high cholesterol.